Article By:
Benzinga
Monday, December 13, 2021 12:11 PM EDT
The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash transaction.